A review of life science current events reported by MedCity News this week:
Best practices in healthcare social media. Social media in healthcare is used to further patient outreach, dispense helpful medical advice, and share their latest news. But it seems that few have moved beyond the basics. Here are a few going the extra mile.
Is it the Midwest’s time to shine for venture capital? The Midwest’s strength in high-growth sectors like biomedical and cleantech should ensure that the region stays an attractive place for investors, industry insiders predict (counterpoint: new investment ventures still struggle to get off the ground).
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Dr. Steven Nissen as FDA deputy commissioner? He’s a long shot. But Cleveland Clinic cardiologist Dr. Steven Nissen may be exactly what the troubled U.S. Food and Drug Administration needs (though not everyone agrees).
Morgan Stanley downgrades St. Jude. The medical devicemaker enjoyed a stellar 2010, mostly due to impressive growth in its pacemaker and implantable cardioverter defibrillator business. But the party may soon be over.
Boston Scientific buys Intelect Medical after all. We called this sale two weeks ago. What we didn’t have nailed down was Intelect Medical’s buyer, which turned out to be current investor Boston Scientific. The sale speaks to the interest in deep brain stimulation and turns into a huge win for Cleveland Clinic Innovations, giving the health system’s commercialization arm its biggest exit yet.
